Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

Documenti analoghi

• Disparities in diabetes burden in China and globally, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
  di: Min Yin, et al.
  Pubblicazione: (2025)
• Global, regional and national burden of ischaemic heart disease attributable to high body mass index and low physical activity from 1990 to 2021
  di: Wenwen Lin, et al.
  Pubblicazione: (2025)
• Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
  di: Xinjiang Dong, et al.
  Pubblicazione: (2025)
• Global and regional estimates of hip fracture burden associated with type 1 diabetes from 1990 to 2021
  di: Jing Li, et al.
  Pubblicazione: (2024)
• Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
  di: Jun‐Qiao An, et al.
  Pubblicazione: (2025)